IGF1 and prostate cancer: In addition to these studies of overall prostate cancer, in a case-only study in the PHS and Health Professionals Follow-Up Study, Ma et al. found no evidence for an association of free IGF-I with risk of lethal compared to nonlethal prostate cancer (524 nonlethal, 434 lethal cases) [18].